Latest Pharmacy News
Review Shows Most Obesity Drugs Do Not Aid Quality of Life, Heart Health
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
2017 to 2022 Saw More Than Doubling in Use of GLP-1 Receptor Agonists
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Withdrawal From Medetomidine Increasingly Seen in ICUs 
Financial Incentives Boost Tobacco Abstinence in Underserved Adults Pharmacy Conference Highlights
Pharmacy Monthly Briefings
Pharmacy Conference News
Stay Connected
